Hydroxyzine HCl — Membership Pricing

Related medications

Other medications associated with the same conditions in this catalog.

Also listed for Pruritus

• Cetirizine

Also listed for Urticaria/Pruritus (Hives/Itching)

• Cetirizine 10 mg tabs

What Hydroxyzine HCl is approved for (FDA label)

For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested. Useful in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses and in histamine-mediated pruritus. As a sedative when used as a premedication and following general anesthesia, hydrOXYzine may potentiate meperidine and barbiturates , so their use in pre-anesthetic adjunctive therapy should be modified on an individual basis. Atropine and other belladonna alkaloids are not affected by the drug. HydrOXYzine is not known to interfere with the action of digitalis in any way and it may be used concurrently with this agent.

Source: Read the full FDA label on DailyMed. Label effective date: September 8, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Hydroxyzine HCl (FDA label)

Side effects reported with the administration of hydrOXYzine hydrochloride are usually mild and transitory in nature. Anticholinergic: Dry mouth. Central Nervous System: Drowsiness is usually transitory and may disappear in a few days of continued therapy or upon reduction of dose. Involuntary motor activity including rare instances of tremor and convulsions have been reported, usually with doses considerably higher than those recommended. Clinically significant respiratory depression has not been reported at recommended doses. In post-marketing experience, the following additional undesirable effects have been reported: Cardiac System: QT prolongation, Torsade de Pointes. Body as a Whole: allergic reaction. Nervous System : headache. Psychiatric: hallucination.

Source: FDA prescribing information (DailyMed). Set ID: 58d99cf6-2319-410b-b8be-de9c304541b6. SPL document ID: 5afc478b-c131-fcff-e063-6394a90aad18. Label effective date: September 8, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Hydroxyzine HCl (FDA label)

Oral hydrOXYzine hydrochloride is contraindicated in patients with known hypersensitivity to hydrOXYzine hydrochloride products, and in patients with known hypersensitivity to cetirizine hydrochloride or levocetirizine hydrochloride. HydrOXYzine is contraindicated in patients with a prolonged QT interval. HydrOXYzine, when administered to the pregnant mouse, rat, and rabbit induced fetal abnormalities in the rat and mouse at doses substantially above the human therapeutic range. Clinical data in human beings are inadequate to establish safety in early pregnancy. Until such data are available, hydrOXYzine is contraindicated in early pregnancy. HydrOXYzine is contraindicated for patients who have shown a previous hypersensitivity to any component of this medication.

Source: FDA prescribing information (DailyMed). Set ID: 58d99cf6-2319-410b-b8be-de9c304541b6. SPL document ID: 5afc478b-c131-fcff-e063-6394a90aad18. Label effective date: September 8, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.